Immunology, Infection, and Inflammation Program


Tumor cells often involve changes that should make them appear 'foreign' to the body's immune system. Thus, these tumors must develop strategies to either suppress or evade the patient's immune system. There is tremendous therapeutic potential in working to strengthen the patient's immune response to the tumor, as well as the potential for artificially inducing an appropriate immune response against a tumor. These types of therapies are often very effective as an adjunct to more traditional therapies and add another valuable tool to the translational arsenal.

Arnold H. Zea, Ph.D.- LSU Augusto Ochoa, M.D. - LSU
Diego Aviles - LSU Ivona V. Pandrea, M.D., Ph.D. - Tulane
John Estrada, MD - LSU Jovany Zabaleta, Ph.D - LSU
Michael Lan - LSU Shulin Li - LSU
Madhwa H. G. Raj, MSc, PhD - LSU Dario Marchetti - LSU
Maureen Shuh, Ph.D. - Xavier Michael Hagensee, M.D. - LSU
Cleveland Moore - LSU Seth Pincus - LSU
Alistair Ramsay - LSU Samuel J. Landry, Ph.D. - Tulane
Judd Shellito - LSU Srikanta Dash, Ph.D. - Tulane
Joy Sturtevant - LSU Vecihi Batuman, M.D. - Tulane
Julia Volaufova - LSU Yan Cui, Ph.D. - LSU


 

Our Partners